Soligenix (SNGX) Current Assets (2010 - 2026)
Soligenix's (SNGX) quarterly Current Assets came in at $6.6 million in Q1 2026, down 14.08% YoY from $7.6 million in Q1 2025, and down 25.81% on a QoQ basis from $8.8 million in Q4 2025.
Soligenix (SNGX) Current Assets (2010 - 2026) Analysis & Trends
Soligenix (SNGX) has 17 years of Current Assets data on file, last reported at $6.6 million in Q1 2026.
- Quarterly Current Assets fell 14.08% year-over-year to $6.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.6 million (down 14.08% YoY) and the FY2025 annual result came in at $8.8 million, changed 0.23% from the prior year.
- Current Assets slipped to $6.6 million in Q1 2026, from $8.8 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $23.5 million in Q1 2022 to a low of $5.3 million in Q2 2025.
- A 5-year average of $11.5 million and a median of $10.3 million in 2024 frame the typical range for Current Assets.
- Annual changes were most pronounced in 2023 — Current Assets slumped 54.32% — and 2025, when it grew 5.57%.
- Tracing SNGX's Current Assets over 5 years: stood at $13.9 million in 2022, then slumped by 31.37% to $9.5 million in 2023, then slipped by 7.14% to $8.8 million in 2024, then grew by 0.23% to $8.8 million in 2025, then fell by 25.81% to $6.6 million in 2026.
- The last three Current Assets figures came in at $6.6 million (Q1 2026), $8.8 million (Q4 2025), and $10.9 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.23 Bn | 132.38 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 86.97 Bn | 78.97 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 65.29 Bn | 60.11 Bn | 1.37 Bn | 8.07 Bn |
| 4 | Moderna | 59.88 Bn | 54.74 Bn | 52.00 Mn | 5.82 Bn |
| 5 | BeOne Medicines | 42.20 Bn | 37.11 Bn | 1.53 Bn | 7.22 Bn |
| 6 | Alnylam Pharmaceuticals | 31.62 Bn | 28.31 Bn | 992.69 Mn | 4.62 Bn |
| 7 | BioNTech SE | 28.69 Bn | 10.30 Bn | 668.28 Mn | 18.80 Bn |
| 8 | Insmed | 27.51 Bn | 26.35 Bn | 358.27 Mn | 1.63 Bn |
| 9 | Royalty Pharma | 27.16 Bn | 26.33 Bn | - | 1.76 Bn |
| 10 | Soligenix | 6.24 Mn | 6.24 Mn | - | 10.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 10.17 Mn |
| Mar 31, 2026 | 6.57 Mn |
| Dec 31, 2025 | 8.85 Mn |
| Sep 30, 2025 | 10.88 Mn |
| Jun 30, 2025 | 5.32 Mn |
| Mar 31, 2025 | 7.64 Mn |
| Dec 31, 2024 | 8.83 Mn |
| Sep 30, 2024 | 10.31 Mn |
| Jun 30, 2024 | 9.66 Mn |
| Mar 31, 2024 | 7.82 Mn |
| Dec 31, 2023 | 9.51 Mn |
| Sep 30, 2023 | 10.97 Mn |
| Jun 30, 2023 | 13.47 Mn |
| Mar 31, 2023 | 10.72 Mn |
| Dec 31, 2022 | 13.85 Mn |
| Sep 30, 2022 | 17.49 Mn |
| Jun 30, 2022 | 20.83 Mn |
| Mar 31, 2022 | 23.47 Mn |
| Dec 31, 2021 | 26.57 Mn |
| Sep 30, 2021 | 29.44 Mn |